Mohammad Ali Aziz-Sultan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embolization, Therapeutic | 42 | 2024 | 1402 | 6.050 |
Why?
|
Polyvinyls | 16 | 2021 | 154 | 5.260 |
Why?
|
Intracranial Aneurysm | 41 | 2024 | 1271 | 5.080 |
Why?
|
Dimethyl Sulfoxide | 11 | 2021 | 250 | 3.690 |
Why?
|
Endovascular Procedures | 30 | 2024 | 2216 | 2.910 |
Why?
|
Subarachnoid Hemorrhage | 19 | 2024 | 1024 | 2.470 |
Why?
|
Cerebral Angiography | 22 | 2020 | 1264 | 2.300 |
Why?
|
Intracranial Arteriovenous Malformations | 5 | 2022 | 360 | 1.300 |
Why?
|
Tantalum | 3 | 2013 | 54 | 1.150 |
Why?
|
Neurosurgical Procedures | 10 | 2022 | 2076 | 1.130 |
Why?
|
Aneurysm, Ruptured | 9 | 2022 | 455 | 1.040 |
Why?
|
Vertebral Artery Dissection | 2 | 2016 | 48 | 1.040 |
Why?
|
Carotid Artery Diseases | 6 | 2022 | 879 | 0.940 |
Why?
|
Retinal Neoplasms | 3 | 2011 | 151 | 0.910 |
Why?
|
Stents | 8 | 2023 | 3195 | 0.910 |
Why?
|
Retinoblastoma | 3 | 2011 | 321 | 0.870 |
Why?
|
Vasospasm, Intracranial | 6 | 2024 | 207 | 0.830 |
Why?
|
Enbucrilate | 2 | 2014 | 29 | 0.810 |
Why?
|
Cerebral Revascularization | 6 | 2022 | 260 | 0.800 |
Why?
|
Brain Ischemia | 10 | 2022 | 3007 | 0.800 |
Why?
|
Surgical Instruments | 3 | 2018 | 381 | 0.780 |
Why?
|
Vertebrobasilar Insufficiency | 3 | 2018 | 113 | 0.750 |
Why?
|
Stroke | 15 | 2024 | 9755 | 0.750 |
Why?
|
Carotid-Cavernous Sinus Fistula | 3 | 2010 | 35 | 0.750 |
Why?
|
Angiofibroma | 2 | 2011 | 55 | 0.730 |
Why?
|
Ophthalmic Artery | 2 | 2011 | 57 | 0.710 |
Why?
|
Punctures | 2 | 2013 | 372 | 0.700 |
Why?
|
Injections, Intra-Arterial | 3 | 2014 | 181 | 0.670 |
Why?
|
Visual Pathways | 2 | 2013 | 557 | 0.650 |
Why?
|
Vascular Neoplasms | 2 | 2011 | 167 | 0.650 |
Why?
|
Ischemia | 3 | 2017 | 1900 | 0.630 |
Why?
|
Melphalan | 2 | 2011 | 421 | 0.630 |
Why?
|
Nasopharyngeal Neoplasms | 2 | 2011 | 290 | 0.620 |
Why?
|
Brain Infarction | 3 | 2019 | 286 | 0.610 |
Why?
|
Vertebral Artery | 5 | 2017 | 185 | 0.580 |
Why?
|
Neuronavigation | 1 | 2019 | 168 | 0.580 |
Why?
|
Treatment Outcome | 54 | 2024 | 65371 | 0.570 |
Why?
|
Thrombectomy | 5 | 2024 | 676 | 0.570 |
Why?
|
Carotid Artery, External | 1 | 2017 | 37 | 0.560 |
Why?
|
Moyamoya Disease | 4 | 2022 | 274 | 0.560 |
Why?
|
Myxoma | 1 | 2017 | 114 | 0.550 |
Why?
|
Embolectomy | 1 | 2017 | 130 | 0.550 |
Why?
|
Renal Artery Obstruction | 1 | 2017 | 217 | 0.530 |
Why?
|
Brain Stem Infarctions | 1 | 2016 | 31 | 0.530 |
Why?
|
Angiography, Digital Subtraction | 6 | 2021 | 331 | 0.520 |
Why?
|
Renal Artery | 1 | 2017 | 354 | 0.520 |
Why?
|
Neurosurgery | 1 | 2022 | 682 | 0.510 |
Why?
|
Craniotomy | 3 | 2017 | 736 | 0.500 |
Why?
|
Cranial Nerve Diseases | 2 | 2013 | 111 | 0.500 |
Why?
|
Cerebral Infarction | 4 | 2016 | 969 | 0.490 |
Why?
|
Embolism | 1 | 2017 | 401 | 0.460 |
Why?
|
Heart Neoplasms | 1 | 2017 | 374 | 0.450 |
Why?
|
Glomus Jugulare Tumor | 1 | 2013 | 35 | 0.450 |
Why?
|
Cerebellopontine Angle | 1 | 2013 | 53 | 0.440 |
Why?
|
Optic Chiasm | 1 | 2013 | 91 | 0.440 |
Why?
|
Preoperative Care | 5 | 2019 | 2258 | 0.440 |
Why?
|
Cerebral Arterial Diseases | 1 | 2013 | 82 | 0.430 |
Why?
|
Epistaxis | 1 | 2014 | 117 | 0.430 |
Why?
|
Oropharynx | 1 | 2014 | 139 | 0.430 |
Why?
|
Infratentorial Neoplasms | 1 | 2013 | 99 | 0.420 |
Why?
|
Cerebral Veins | 1 | 2014 | 157 | 0.410 |
Why?
|
Propensity Score | 4 | 2024 | 1969 | 0.400 |
Why?
|
Middle Aged | 62 | 2024 | 223492 | 0.370 |
Why?
|
Subarachnoid Space | 1 | 2011 | 79 | 0.370 |
Why?
|
Carotid Artery, Internal | 6 | 2014 | 440 | 0.370 |
Why?
|
Tissue Plasminogen Activator | 3 | 2024 | 1165 | 0.370 |
Why?
|
Fibrinolytic Agents | 3 | 2024 | 2080 | 0.360 |
Why?
|
Decompressive Craniectomy | 3 | 2017 | 76 | 0.360 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2017 | 952 | 0.360 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2011 | 87 | 0.360 |
Why?
|
Paracoccidioidomycosis | 1 | 2009 | 10 | 0.350 |
Why?
|
Humans | 111 | 2024 | 768166 | 0.340 |
Why?
|
Retinal Artery | 1 | 2010 | 109 | 0.340 |
Why?
|
Orbit | 2 | 2010 | 459 | 0.340 |
Why?
|
Operating Rooms | 1 | 2016 | 790 | 0.330 |
Why?
|
Retrospective Studies | 41 | 2024 | 81762 | 0.330 |
Why?
|
Magnetic Resonance Angiography | 7 | 2019 | 1429 | 0.330 |
Why?
|
Aneurysm, Infected | 1 | 2009 | 81 | 0.320 |
Why?
|
Blindness | 1 | 2013 | 587 | 0.320 |
Why?
|
Carotid Body Tumor | 1 | 2009 | 34 | 0.310 |
Why?
|
Carcinoma, Renal Cell | 2 | 2013 | 3187 | 0.310 |
Why?
|
Brain Stem | 1 | 2013 | 859 | 0.310 |
Why?
|
Brain Neoplasms | 5 | 2019 | 9118 | 0.300 |
Why?
|
Laser Coagulation | 1 | 2010 | 334 | 0.300 |
Why?
|
Blood Vessel Prosthesis Implantation | 3 | 2024 | 1456 | 0.300 |
Why?
|
Catheterization | 2 | 2010 | 1430 | 0.300 |
Why?
|
Catheters | 1 | 2011 | 427 | 0.290 |
Why?
|
Male | 65 | 2024 | 364719 | 0.290 |
Why?
|
Infusions, Intra-Arterial | 3 | 2014 | 220 | 0.280 |
Why?
|
Monitoring, Intraoperative | 1 | 2014 | 948 | 0.280 |
Why?
|
Female | 68 | 2024 | 397192 | 0.280 |
Why?
|
Kidney Neoplasms | 2 | 2013 | 4282 | 0.270 |
Why?
|
Scalp | 1 | 2009 | 391 | 0.270 |
Why?
|
Angioplasty, Balloon | 2 | 2009 | 592 | 0.270 |
Why?
|
Blood Coagulation Disorders | 1 | 2009 | 350 | 0.260 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 614 | 0.260 |
Why?
|
Aged | 46 | 2024 | 171504 | 0.260 |
Why?
|
Blood Vessel Prosthesis | 3 | 2024 | 956 | 0.250 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 594 | 0.250 |
Why?
|
Drainage | 1 | 2011 | 1183 | 0.240 |
Why?
|
Saphenous Vein | 2 | 2018 | 519 | 0.240 |
Why?
|
Fluoroscopy | 3 | 2016 | 947 | 0.240 |
Why?
|
Glioma | 2 | 2019 | 3503 | 0.240 |
Why?
|
Hemangioma | 1 | 2009 | 727 | 0.230 |
Why?
|
Physicians | 1 | 2022 | 4598 | 0.230 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 2 | 2014 | 69 | 0.220 |
Why?
|
Adult | 40 | 2024 | 223646 | 0.220 |
Why?
|
Reperfusion | 2 | 2014 | 266 | 0.220 |
Why?
|
Hemodynamics | 1 | 2014 | 4194 | 0.210 |
Why?
|
Vascular Surgical Procedures | 3 | 2018 | 1506 | 0.210 |
Why?
|
Afghanistan | 1 | 2022 | 78 | 0.210 |
Why?
|
rho-Associated Kinases | 1 | 2024 | 290 | 0.210 |
Why?
|
Cerebral Cortex | 1 | 2019 | 5812 | 0.210 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.200 |
Why?
|
Hemianopsia | 2 | 2013 | 121 | 0.200 |
Why?
|
Thrombocytopenia | 1 | 2009 | 1179 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 8 | 2019 | 20760 | 0.190 |
Why?
|
Magnetic Resonance Imaging | 11 | 2019 | 36743 | 0.180 |
Why?
|
Angiography | 5 | 2014 | 1597 | 0.180 |
Why?
|
Aneurysm, False | 2 | 2017 | 263 | 0.180 |
Why?
|
Radiography | 5 | 2014 | 6983 | 0.170 |
Why?
|
Postoperative Complications | 9 | 2024 | 15832 | 0.160 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 277 | 0.160 |
Why?
|
Aged, 80 and over | 16 | 2024 | 59629 | 0.160 |
Why?
|
Cranial Sinuses | 1 | 2019 | 68 | 0.160 |
Why?
|
Meningioma | 2 | 2021 | 1220 | 0.160 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2020 | 125 | 0.150 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1253 | 0.150 |
Why?
|
Collateral Circulation | 1 | 2019 | 291 | 0.150 |
Why?
|
Head and Neck Neoplasms | 2 | 2012 | 2931 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 3 | 2019 | 4063 | 0.150 |
Why?
|
Regional Blood Flow | 2 | 2013 | 1500 | 0.150 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 279 | 0.150 |
Why?
|
Infarction | 2 | 2022 | 247 | 0.140 |
Why?
|
Young Adult | 12 | 2019 | 60066 | 0.140 |
Why?
|
Perioperative Period | 1 | 2019 | 253 | 0.140 |
Why?
|
Thromboembolism | 1 | 2024 | 1004 | 0.140 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 320 | 0.140 |
Why?
|
Paresthesia | 1 | 2018 | 160 | 0.140 |
Why?
|
Databases, Bibliographic | 1 | 2017 | 128 | 0.140 |
Why?
|
Blood Loss, Surgical | 2 | 2011 | 642 | 0.140 |
Why?
|
Cross Infection | 2 | 2016 | 1426 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2023 | 39348 | 0.130 |
Why?
|
Vascular Grafting | 1 | 2018 | 163 | 0.130 |
Why?
|
Drug Combinations | 2 | 2013 | 2089 | 0.130 |
Why?
|
Prospective Studies | 9 | 2023 | 54926 | 0.130 |
Why?
|
Aneurysm | 1 | 2019 | 343 | 0.130 |
Why?
|
Reaction Time | 1 | 2022 | 2101 | 0.120 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2024 | 2763 | 0.120 |
Why?
|
Occipital Lobe | 1 | 2017 | 376 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2022 | 2055 | 0.120 |
Why?
|
Patient Readmission | 3 | 2019 | 3288 | 0.120 |
Why?
|
Graft Occlusion, Vascular | 1 | 2018 | 538 | 0.120 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 810 | 0.120 |
Why?
|
Serotonin Agents | 1 | 2014 | 29 | 0.120 |
Why?
|
Tracheostomy | 1 | 2018 | 430 | 0.120 |
Why?
|
Blister | 1 | 2014 | 88 | 0.120 |
Why?
|
Endarterectomy, Carotid | 1 | 2019 | 556 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2014 | 8542 | 0.110 |
Why?
|
Basilar Artery | 1 | 2014 | 207 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11878 | 0.110 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2017 | 486 | 0.110 |
Why?
|
Time Factors | 9 | 2021 | 40218 | 0.110 |
Why?
|
Aspirin | 1 | 2024 | 3135 | 0.100 |
Why?
|
Registries | 5 | 2024 | 8375 | 0.100 |
Why?
|
Adolescent | 13 | 2019 | 89169 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 320 | 0.100 |
Why?
|
Paralysis | 1 | 2013 | 250 | 0.100 |
Why?
|
Inpatients | 3 | 2018 | 2566 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8748 | 0.100 |
Why?
|
Age Distribution | 2 | 2015 | 2873 | 0.100 |
Why?
|
Microsurgery | 1 | 2017 | 800 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2024 | 3589 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15948 | 0.090 |
Why?
|
Tinnitus | 1 | 2013 | 197 | 0.090 |
Why?
|
Eye Enucleation | 1 | 2011 | 128 | 0.090 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2012 | 141 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
Accidents, Traffic | 1 | 2016 | 818 | 0.090 |
Why?
|
Carotid Artery, Common | 1 | 2011 | 174 | 0.090 |
Why?
|
Needles | 1 | 2013 | 461 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1443 | 0.090 |
Why?
|
Ophthalmoscopy | 1 | 2011 | 172 | 0.090 |
Why?
|
Patient Transfer | 1 | 2017 | 792 | 0.090 |
Why?
|
Neuralgia | 1 | 2017 | 621 | 0.090 |
Why?
|
Hospital Mortality | 4 | 2017 | 5349 | 0.090 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2010 | 94 | 0.090 |
Why?
|
Sclerosis | 1 | 2010 | 211 | 0.090 |
Why?
|
Skin Neoplasms | 1 | 2009 | 5863 | 0.090 |
Why?
|
Nerve Block | 1 | 2017 | 716 | 0.090 |
Why?
|
Spinal Puncture | 1 | 2011 | 286 | 0.080 |
Why?
|
Hypoglossal Nerve Diseases | 1 | 2009 | 8 | 0.080 |
Why?
|
Nasal Obstruction | 1 | 2011 | 163 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2015 | 804 | 0.080 |
Why?
|
Synovial Cyst | 1 | 2009 | 34 | 0.080 |
Why?
|
Etoposide | 1 | 2010 | 639 | 0.080 |
Why?
|
Clostridium Infections | 1 | 2016 | 562 | 0.080 |
Why?
|
Atlanto-Axial Joint | 1 | 2009 | 60 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2019 | 2650 | 0.080 |
Why?
|
Arteries | 1 | 2013 | 1127 | 0.080 |
Why?
|
Cerebrovascular Circulation | 2 | 2021 | 2725 | 0.080 |
Why?
|
Child | 8 | 2017 | 80917 | 0.080 |
Why?
|
MicroRNAs | 1 | 2024 | 3803 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9538 | 0.080 |
Why?
|
Anticoagulants | 1 | 2024 | 4852 | 0.080 |
Why?
|
Nasopharynx | 1 | 2011 | 420 | 0.070 |
Why?
|
Vincristine | 1 | 2010 | 1040 | 0.070 |
Why?
|
North America | 2 | 2022 | 1289 | 0.070 |
Why?
|
Steroids | 1 | 2013 | 938 | 0.070 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13676 | 0.070 |
Why?
|
Cyclosporine | 1 | 2010 | 777 | 0.070 |
Why?
|
Calcinosis | 2 | 2014 | 1481 | 0.070 |
Why?
|
Carboplatin | 1 | 2010 | 797 | 0.070 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.070 |
Why?
|
Anxiety | 1 | 2022 | 4672 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3109 | 0.070 |
Why?
|
Zygapophyseal Joint | 1 | 2009 | 129 | 0.070 |
Why?
|
Epilepsy | 1 | 2022 | 3327 | 0.070 |
Why?
|
Intracranial Embolism | 1 | 2008 | 188 | 0.070 |
Why?
|
Intraoperative Complications | 2 | 2010 | 1171 | 0.070 |
Why?
|
Spinal Cord | 1 | 2014 | 1811 | 0.060 |
Why?
|
Veins | 1 | 2010 | 769 | 0.060 |
Why?
|
Incidence | 4 | 2021 | 21538 | 0.060 |
Why?
|
Infant | 4 | 2012 | 36535 | 0.060 |
Why?
|
Insulin | 1 | 2020 | 6607 | 0.060 |
Why?
|
Blood Glucose | 1 | 2020 | 6430 | 0.060 |
Why?
|
Fluorescein Angiography | 1 | 2010 | 1086 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2011 | 1189 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2410 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 41754 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5995 | 0.050 |
Why?
|
Prevalence | 1 | 2021 | 15869 | 0.050 |
Why?
|
Ultrasonography | 1 | 2017 | 6004 | 0.050 |
Why?
|
Circle of Willis | 1 | 2023 | 77 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2013 | 1805 | 0.050 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11519 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6847 | 0.050 |
Why?
|
Length of Stay | 4 | 2019 | 6498 | 0.050 |
Why?
|
Ischemic Attack, Transient | 1 | 2009 | 877 | 0.050 |
Why?
|
Syndrome | 1 | 2009 | 3272 | 0.050 |
Why?
|
Blood Pressure | 2 | 2021 | 8543 | 0.050 |
Why?
|
Postoperative Care | 2 | 2024 | 1480 | 0.050 |
Why?
|
Data Collection | 1 | 2011 | 3327 | 0.050 |
Why?
|
Risk Assessment | 2 | 2024 | 24315 | 0.050 |
Why?
|
Age Factors | 4 | 2024 | 18412 | 0.050 |
Why?
|
Temporal Arteries | 1 | 2023 | 155 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3522 | 0.050 |
Why?
|
Middle Cerebral Artery | 1 | 2023 | 271 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3467 | 0.050 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2655 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2709 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1854 | 0.050 |
Why?
|
Milrinone | 1 | 2021 | 86 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 74944 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 232 | 0.040 |
Why?
|
Retreatment | 1 | 2022 | 598 | 0.040 |
Why?
|
Visual Acuity | 1 | 2010 | 2714 | 0.040 |
Why?
|
Sagittal Sinus Thrombosis | 1 | 2019 | 11 | 0.040 |
Why?
|
Lateral Sinus Thrombosis | 1 | 2019 | 7 | 0.040 |
Why?
|
Child, Preschool | 3 | 2012 | 42669 | 0.040 |
Why?
|
Algorithms | 2 | 2017 | 14164 | 0.040 |
Why?
|
Spectrum Analysis | 1 | 2021 | 449 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2021 | 323 | 0.040 |
Why?
|
Glioblastoma | 1 | 2014 | 3464 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10590 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 294 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10399 | 0.040 |
Why?
|
Phlebography | 1 | 2019 | 326 | 0.040 |
Why?
|
Prognosis | 4 | 2021 | 30010 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2014 | 4423 | 0.040 |
Why?
|
Pediatrics | 1 | 2012 | 3629 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2024 | 2125 | 0.040 |
Why?
|
Cerebellar Diseases | 1 | 2019 | 227 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2021 | 1375 | 0.030 |
Why?
|
Recurrence | 2 | 2021 | 8509 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 365 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 202 | 0.030 |
Why?
|
Odds Ratio | 2 | 2021 | 9669 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1737 | 0.030 |
Why?
|
Acute Disease | 2 | 2018 | 7243 | 0.030 |
Why?
|
Hospital Charges | 1 | 2017 | 347 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11244 | 0.030 |
Why?
|
United States | 6 | 2019 | 73039 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1363 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2018 | 914 | 0.030 |
Why?
|
Vascular Patency | 1 | 2018 | 917 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18349 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 772 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2024 | 2008 | 0.030 |
Why?
|
Databases, Factual | 2 | 2021 | 8080 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27360 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14729 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 22291 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13290 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 9015 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1221 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4539 | 0.030 |
Why?
|
Cell Movement | 1 | 2024 | 5210 | 0.030 |
Why?
|
Hypoglycemia | 1 | 2020 | 895 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2019 | 859 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2022 | 1923 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2013 | 574 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2019 | 5889 | 0.020 |
Why?
|
Hydrocephalus | 1 | 2017 | 768 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2278 | 0.020 |
Why?
|
Forehead | 1 | 2010 | 75 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2010 | 121 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2998 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13014 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2024 | 10474 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 2008 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2014 | 979 | 0.020 |
Why?
|
Eyelids | 1 | 2010 | 278 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1805 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5884 | 0.020 |
Why?
|
Reoperation | 1 | 2017 | 4329 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2024 | 11928 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2815 | 0.020 |
Why?
|
Hypertension | 2 | 2019 | 8616 | 0.020 |
Why?
|
Insurance, Health | 1 | 2017 | 2517 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13671 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10101 | 0.010 |
Why?
|
Venous Thromboembolism | 1 | 2017 | 1883 | 0.010 |
Why?
|
Hospitals | 1 | 2017 | 3886 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12077 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12543 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9092 | 0.010 |
Why?
|
Quality Improvement | 1 | 2017 | 3857 | 0.010 |
Why?
|
Animals | 1 | 2014 | 169246 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12840 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6568 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 26422 | 0.010 |
Why?
|